GUCY2C and intestinal disorder: The activation of the GC-C/cGMP pathway via guanylin and uroguanylin has been well established in various species; this pathway was shown to be essential in the restoration of mucosal barrier function during intestinal disorders, and the administration of synthetic agonists of this cascade can have beneficial effects.